403 related articles for article (PubMed ID: 29753603)
1. Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents.
Rose DK; Bar B
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2049-2058. PubMed ID: 29753603
[TBL] [Abstract][Full Text] [Related]
2. Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal.
Samos M; Stanciakova L; Skornova I; Bolek T; Kovar F; Stasko J; Galajda P; Mokan M; Kubisz P
Curr Drug Metab; 2017; 18(7):643-650. PubMed ID: 28412907
[TBL] [Abstract][Full Text] [Related]
3. Reversal of direct oral anticoagulants.
Almegren M
Vasc Health Risk Manag; 2017; 13():287-292. PubMed ID: 28769570
[TBL] [Abstract][Full Text] [Related]
4. Indications and Methods of Anticoagulation Reversal.
Holzmacher JL; Sarani B
Surg Clin North Am; 2017 Dec; 97(6):1291-1305. PubMed ID: 29132510
[TBL] [Abstract][Full Text] [Related]
5. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
6. Measurement and reversal of the direct oral anticoagulants.
Samuelson BT; Cuker A
Blood Rev; 2017 Jan; 31(1):77-84. PubMed ID: 27625113
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the development of specific antidotes for target-specific oral anticoagulants.
Mo Y; Yam FK
Pharmacotherapy; 2015 Feb; 35(2):198-207. PubMed ID: 25644580
[TBL] [Abstract][Full Text] [Related]
8. Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs).
Hussain SS; Tyroch AH; Mukherjee D
Cardiovasc Hematol Agents Med Chem; 2017; 14(2):76-81. PubMed ID: 27215215
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.
Enriquez A; Lip GY; Baranchuk A
Europace; 2016 Jul; 18(7):955-64. PubMed ID: 25816811
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants.
Andresen K; Atar D; Gjertsen E; Ghanima W; Roseth S; Johansen OE
Scand Cardiovasc J; 2018 Jun; 52(3):156-162. PubMed ID: 29569500
[TBL] [Abstract][Full Text] [Related]
11. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
12. Reversal Agents for the Direct Oral Anticoagulants.
Ansell JE
Hematol Oncol Clin North Am; 2016 Oct; 30(5):1085-98. PubMed ID: 27637309
[TBL] [Abstract][Full Text] [Related]
13. Decision-making about the use of non-vitamin K oral anticoagulant therapies for patients with atrial fibrillation.
Eckman MH
J Thromb Thrombolysis; 2016 Feb; 41(2):234-40. PubMed ID: 26343041
[TBL] [Abstract][Full Text] [Related]
14. Reversal strategies in patients treated with direct oral anticoagulants.
Gressenberger P
Vasa; 2019 Aug; 48(5):389-392. PubMed ID: 30719950
[No Abstract] [Full Text] [Related]
15. Direct oral anticoagulants: a review on the current role and scope of reversal agents.
Chaudhary R; Sharma T; Garg J; Sukhi A; Bliden K; Tantry U; Turagam M; Lakkireddy D; Gurbel P
J Thromb Thrombolysis; 2020 Feb; 49(2):271-286. PubMed ID: 31512202
[TBL] [Abstract][Full Text] [Related]
16. Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab.
Hu TY; Vaidya VR; Asirvatham SJ
Vasc Health Risk Manag; 2016; 12():35-44. PubMed ID: 26937198
[TBL] [Abstract][Full Text] [Related]
17. Monitoring and reversal strategies for new oral anticoagulants.
Vanden Daelen S; Peetermans M; Vanassche T; Verhamme P; Vandermeulen E
Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):95-103. PubMed ID: 25431993
[TBL] [Abstract][Full Text] [Related]
18. Current evidence of oral anticoagulant reversal: A systematic review.
Tornkvist M; Smith JG; Labaf A
Thromb Res; 2018 Feb; 162():22-31. PubMed ID: 29258056
[TBL] [Abstract][Full Text] [Related]
19. An Update on the "Novel" and Direct Oral Anticoagulants, and Long-Term Anticoagulant Therapy.
Djulbegovic M; Lee AI
Clin Chest Med; 2018 Sep; 39(3):583-593. PubMed ID: 30122182
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant Reversal in Gastrointestinal Bleeding: Review of Treatment Guidelines.
Milling TJ; Refaai MA; Sengupta N
Dig Dis Sci; 2021 Nov; 66(11):3698-3714. PubMed ID: 33403486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
